Filana Therapeutics (FLNA) Q3 2018 Earnings Report
MX:FLNA Q3 2018 EPS Results
- Actual EPS
- -MXN 2.07
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 7.52
MX:FLNA Q3 2018 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 10/29/2018
- Time
- TBA
- Conference Call
- Monday, October 29, 2018
MX:FLNA Upcoming Earnings
Filana Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:FLNA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -4.60- | -4.13 | ― | ― |
| Aug 05, 2026 | 2026 (Q2) | -4.23-3.38 | -17.29 | 80.43% (+13.91) | |
| May 07, 2026 | 2026 (Q1) | -4.32-3.95 | -9.02 | 56.25% (+5.07) | |
| Mar 12, 2026 | 2025 (Q4) | -5.64-4.89 | -10.71 | 54.39% (+5.83) | |
| Nov 12, 2025 | 2025 (Q3) | -5.07-4.13 | -10.9 | 62.07% (+6.77) | |
| Aug 14, 2025 | 2025 (Q2) | ―-17.29 | 2.44 | -807.69% (-19.73) | |
| May 08, 2025 | 2025 (Q1) | ―-9.02 | -8.08 | -11.63% (-0.94) | |
| Mar 03, 2025 | 2024 (Q4) | -10.96-10.71 | -9.4 | -14.00% (-1.32) | |
| Nov 07, 2024 | 2024 (Q3) | -13.72-10.90 | -11.46 | 4.92% (+0.56) | |
| Aug 08, 2024 | 2024 (Q2) | -7.652.44 | -11.84 | 120.63% (+14.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed